CoreWeave stock slips in New York as Nvidia deal digested; CRWV traders eye next earnings

CoreWeave stock slips in New York as Nvidia deal digested; CRWV traders eye next earnings

New York, Jan 28, 2026, 10:58 EST — Regular session

  • CoreWeave shares surged early but then plunged, showing sharp swings in morning trading
  • The main driver continues to be Nvidia’s $2 billion equity purchase and its broadened partnership.
  • Investors are focused on financing, power buildout, and the upcoming quarterly report

Shares of CoreWeave, Inc. (CRWV) dipped 1.3% to $107.44 in morning trading Wednesday, moving between $107.20 and $114.50. The stock kicked off the session at $114.17, with roughly 12.7 million shares changing hands.

This back-and-forth is crucial since CoreWeave offers one of the clearest signals on demand for AI infrastructure. When trading gets shaky, stocks linked to new data centers and expensive chips tend to see rapid price swings.

Investors are grappling with what “demand” actually reflects at this stage — signed contracts or just optimism. CoreWeave offers access to GPUs, the graphics processors that power AI training and operations. These projects need substantial payments, reliable power connections, and consistent usage to really matter.

Nvidia and CoreWeave announced Monday an expanded partnership to accelerate the development of over 5 gigawatts of “AI factories” — massive data centers designed specifically for AI — by 2030. Nvidia poured $2 billion into CoreWeave at $87.20 a share. The two said CoreWeave will roll out multiple generations of Nvidia technology and help validate its AI software for wider adoption among cloud providers and enterprises. “AI is entering its next frontier and driving the largest infrastructure buildout in human history,” said Nvidia CEO Jensen Huang. CoreWeave CEO Michael Intrator added, “AI succeeds when software, infrastructure, and operations are designed together.” (CoreWeave)

CoreWeave shares jumped 9% in premarket trading Monday, Reuters reported, following Nvidia’s move to become the company’s second-largest shareholder. CoreWeave clarified that the funds will be used for data-center expansion, research, and hiring—not for purchasing Nvidia processors—addressing investor concerns about potential circular financing in AI-related chip deals. (Reuters)

Intrator has emphasized that the buildout is driven by contracts. At the World Economic Forum in Davos, he stated, “We are building our infrastructure in response to signed contracts with long-term demand,” highlighting “inference”—the active use of an AI model in production—as a key indicator before the company invests capital. (Axios)

Nvidia shares rose 1.3% on Wednesday, while CoreWeave showed more volatility, grabbing the spotlight for traders focused on the AI-buildout story.

The funding question remains unresolved despite Nvidia’s involvement, with CoreWeave among the names tangled in “AI bubble” concerns over who will foot the bill for the data-center surge. A filing revealed CoreWeave sold 22,935,780 shares to Nvidia through a private placement—a direct sale outside the public market—and flagged that parts of their partnership depend on future agreements that might not materialize or could come with different terms. (SEC)

Coming up next, the latest quarterly results are due; TradingView’s earnings calendar has Feb. 18 marked for the report. Investors will be focused on booked demand, financing details, and the pace at which CoreWeave plans to expand its power and data-center capacity. (Tradingview)

Stock Market Today

  • Medtronic (MDT) Valuation Analysis: Is the Stock Fairly Priced?
    January 28, 2026, 11:32 AM EST. Medtronic's shares recently closed at $100.69, showing steady returns: 12.9% over one year and 32.7% over three. A Discounted Cash Flow (DCF) valuation estimates an intrinsic value of $102.82, suggesting the stock is about 2.1% undervalued-close to fair value. The DCF method projects free cash flow rising from $5.33 billion to nearly $9.94 billion by 2035, reflecting solid long-term growth prospects. Investors weigh these figures alongside Medtronic's ongoing product updates and market position as a major medical technology company. Overall, the stock appears appropriately priced relative to expectations, with undervaluation signals modest, highlighting the importance of ongoing monitoring for shifts in market sentiment or fundamentals.
Natural gas prices cool after storm spike — EQT and gas stocks hold up as traders eye storage
Previous Story

Natural gas prices cool after storm spike — EQT and gas stocks hold up as traders eye storage

BigBear.ai stock pops early on AD Ports partnership — and a share-vote deadline is looming
Next Story

BigBear.ai stock pops early on AD Ports partnership — and a share-vote deadline is looming

Go toTop